The independent source for health policy research, polling, and news.
1,481 - 1,500 of 15,455 Results
As Congress remains deadlocked on gun policy, the Biden administration is calling on hospital leaders and doctors to gather more data about gunshot injuries and deaths and step up their violence prevention work.
Michigan and Ohio serve as cautionary tales for states whose voters will decide abortion ballot initiatives this year: Even if the measures pass, it would take time to unwind conflicting laws.
As the Affordable Connectivity Program runs out of money, millions of people face a jump in internet costs or lost connections if federal lawmakers don't pass a funding extension.
Provider groups are disappointed that the Federal Trade Commission’s new rule may not protect those who work for nonprofit hospitals and health care facilities, which employ the largest number of medical professionals.
California is the ninth state to set annual health spending targets for the industry. Already hospitals and doctors are voicing resistance to the fledgling Office of Health Care Affordability, even as they avoid overtly opposing its goals.
At a June 3 congressional hearing that underscored the nation's deep political divide over the coronavirus pandemic response, the longtime National Institutes of Health official addressed the agency’s controversies head-on.
In this episode of “An Arm and a Leg,” the show takes its first look at Medicaid. The program has dropped more than 22 million people since spring 2023, when covid-era protections ended.
High rates of smoking in the LGBTQ+ community, and the ease with which young people can buy a range of nicotine products, is leading several Northern California cities to consider new restrictions on cigarettes, vapes, and cigars.
New York and Michigan recently passed laws allowing local jurisdictions to lower speed limits, and Los Angeles voters backed safer road designs, but enforcement often meets political resistance. The number of pedestrians killed or injured on the road remains high.
KFF Health News gives readers a chance to comment on a recent batch of stories.
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here’s a collection of their appearances.
In a trove of emails brought to light through a congressional probe, a former close adviser to longtime National Institutes of Health official Anthony Fauci spoke of hiding messages from public disclosure.
The spread of an avian flu virus in cattle has again brought public health attention to the potential for a global pandemic. Fighting it would depend, for now, on 1940s technology that makes vaccines from hens’ eggs.
June is when the Supreme Court typically issues rulings in the major cases it hears during that year’s term. This year, those interested in health policy are awaiting decisions in two abortion-related cases and one that could reshuffle the way health policies (and all other federal policies) are made. In this special episode, KFF’s Laurie Sobel, associate director for women’s health policy, joins Julie Rovner for a review of the cases and a preview of how the court might rule.
Most states that saw enrollment in the Obamacare marketplace double from 2020 to 2024 are in the South. But the enhanced federal subsidies that attracted people with $0 premiums and low out-of-pocket costs will expire next year.
One of Montana’s largest safety-net health centers announced it will lay off nearly 10% of its workforce because of revenue losses it attributes to vast Medicaid disenrollments. Such cuts are happening elsewhere too.
A disconnect between two federal programs meant to help keep hospitals afloat discourages struggling rural facilities from accepting the aid.
Federal officials are offering $75 to dairy workers who agree to be tested for bird flu. Advocates say the payments aren’t enough to protect workers from lost wages and health care costs if they test positive.
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
© 2026 KFF